Proton pump inhibitors: Weighing the benefits and risks across various health conditions

被引：1
|
作者：
Sizgoric, Luka [1 ]
Likic, Robert [1 ,2 ,3 ]
机构：
[1] Univ Zagreb, Med Sch, Zagreb, Croatia
[2] Clin Hosp Ctr Zagreb, Dept Internal Med, Div Clin Pharmacol & Therapeut, Zagreb, Croatia
[3] Univ Hosp Ctr Zagreb, Dept Internal Med, Unit Clin Pharmacol, Kispaticeva 12, Zagreb 10000, Croatia
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2024年 / 90卷 / 02期
关键词：
chronic kidney disease; COVID-19; drug interactions; effects; gastric acid secretion; glycemic dysregulation; proton pump inhibitors;
D O I：
10.1111/bcp.15960
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：388 / 391
页数：4
相关论文
共 44 条
  • [21] Prescribing of proton pump inhibitors for gastrointestinal bleeding prophylaxis in the Lebanese outpatient setting: patterns, compliance with guidelines and risks
    Soubra, Lama
    Issa, Mohamed
    INTERNATIONAL JOURNAL OF PHARMACY PRACTICE, 2019, 27 (04) : 386 - 392
  • [22] Opportunities for successful de-escalation of proton pump inhibitors at a federally qualified health center
    Ayoub, Joelle
    McGregor, Jessina C.
    Castner, Rebecca M.
    Singh, Harleen
    BMC PHARMACOLOGY & TOXICOLOGY, 2021, 22 (01)
  • [23] Opportunities for successful de-escalation of proton pump inhibitors at a federally qualified health center
    Joelle Ayoub
    Jessina C. McGregor
    Rebecca M. Castner
    Harleen Singh
    BMC Pharmacology and Toxicology, 22
  • [24] Evolution of the consumption trend of proton pump inhibitors in the Lleida Health Region between 2002 and 2015
    F. Torres-Bondia
    J. de Batlle
    L. Galván
    M. Buti
    F. Barbé
    G. Piñol-Ripoll
    BMC Public Health, 22
  • [25] Evolution of the consumption trend of proton pump inhibitors in the Lleida Health Region between 2002 and 2015
    Torres-Bondia, F.
    de Batlle, J.
    Galvan, L.
    Buti, M.
    Barbe, F.
    Pinol-Ripoll, G.
    BMC PUBLIC HEALTH, 2022, 22 (01)
  • [26] Proton pump inhibitors enhance intestinal permeability via dysbiosis of gut microbiota under stressed conditions in mice
    Takashima, Shingo
    Tanaka, Fumio
    Kawaguchi, Yunoske
    Usui, Yuki
    Fujimoto, Kosuke
    Nadatani, Yuji
    Otani, Koji
    Hosomi, Shuhei
    Nagami, Yasuaki
    Kamata, Noriko
    Taira, Koichi
    Tanigawa, Tetsuya
    Watanabe, Toshio
    Imoto, Seiya
    Uematsu, Satoshi
    Fujiwara, Yasuhiro
    NEUROGASTROENTEROLOGY AND MOTILITY, 2020, 32 (07)
  • [27] Potential Risks Associated With Long-term Use of Proton Pump Inhibitors and the Maintenance Treatment Modality for Patients With Mild Gastroesophageal Reflux Disease
    Kim, Seung Young
    Lee, Kwang Jae
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2024, 30 (04) : 407 - 420
  • [28] Magnitude and Determinants of Long-term Use of Proton Pump Inhibitors Among Portuguese Older Adults in Primary Health Care
    Rodrigues, Daniela A.
    Herdeiro, Maria Teresa
    Mateos-Campos, Ramona
    Figueiras, Adolfo
    Roque, Fatima
    CLINICAL THERAPEUTICS, 2024, 46 (02) : e54 - e58
  • [29] Proton pump inhibitors long term use-trends and patterns over 15 years of a large health maintenance organization
    Rosenberg, Vered
    Tzadok, Roie
    Chodick, Gabriel
    Revital, Kariv
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 (11) : 1576 - 1587
  • [30] Effect of Proton Pump Inhibitors on Risks of Upper and Lower Gastrointestinal Bleeding among Users of Low-Dose Aspirin: A Population-Based Observational Study
    Garcia Rodriguez, Luis A.
    Lanas, Angel
    Soriano-Gabarro, Montse
    Vora, Pareen
    Cea Soriano, Lucia
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
12345